Loading…

Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla

Rationale Chronic fatigue syndrome (CFS) is a common and burdensome illness with a poorly understood pathophysiology, though many of the characteristic symptoms are likely to be of brain origin. The use of high-field proton magnetic resonance spectroscopy (MRS) enables the detection of a range of br...

Full description

Saved in:
Bibliographic Details
Published in:Psychopharmacology 2022-01, Vol.239 (1), p.163-171
Main Authors: Godlewska, Beata R., Williams, Stephen, Emir, Uzay E., Chen, Chi, Sharpley, Ann L., Goncalves, Ana Jorge, Andersson, Monique I., Clarke, William, Angus, Brian, Cowen, Philip J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c541t-a35c289ad5174e6702b18ee8b87556a7cb9545ef3c2a1fc4b64a567553ed68a93
cites cdi_FETCH-LOGICAL-c541t-a35c289ad5174e6702b18ee8b87556a7cb9545ef3c2a1fc4b64a567553ed68a93
container_end_page 171
container_issue 1
container_start_page 163
container_title Psychopharmacology
container_volume 239
creator Godlewska, Beata R.
Williams, Stephen
Emir, Uzay E.
Chen, Chi
Sharpley, Ann L.
Goncalves, Ana Jorge
Andersson, Monique I.
Clarke, William
Angus, Brian
Cowen, Philip J.
description Rationale Chronic fatigue syndrome (CFS) is a common and burdensome illness with a poorly understood pathophysiology, though many of the characteristic symptoms are likely to be of brain origin. The use of high-field proton magnetic resonance spectroscopy (MRS) enables the detection of a range of brain neurochemicals relevant to aetiological processes that have been linked to CFS, for example, oxidative stress and mitochondrial dysfunction. Methods We studied 22 CFS patients and 13 healthy controls who underwent MRS scanning at 7 T with a voxel placed in the anterior cingulate cortex. Neurometabolite concentrations were calculated using the unsuppressed water signal as a reference. Results Compared to controls, CFS patients had lowered levels of glutathione, total creatine and myo -inositol in anterior cingulate cortex. However, when using N-acetylaspartate as a reference metabolite, only myo -inositol levels continued to be significantly lower in CFS participants. Conclusions The changes in glutathione and creatine are consistent with the presence of oxidative and energetic stress in CFS patients and are potentially remediable by nutritional intervention. A reduction in myo -inositol would be consistent with glial dysfunction. However, the relationship of the neurochemical abnormalities to the causation of CFS remains to be established, and the current findings require prospective replication in a larger sample.
doi_str_mv 10.1007/s00213-021-05986-6
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8770374</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A689970178</galeid><sourcerecordid>A689970178</sourcerecordid><originalsourceid>FETCH-LOGICAL-c541t-a35c289ad5174e6702b18ee8b87556a7cb9545ef3c2a1fc4b64a567553ed68a93</originalsourceid><addsrcrecordid>eNp9kk1v1DAQhiMEokvhD3BAlrhwSfFH_BEOSFXFl1TBpZytiTPJukrsrZ0g7b_Hy5aWIoQt2ZLnmdee8VtVLxk9Y5Tqt5lSzkRdlprK1qhaPao2rBG85lTzx9WGUiFqwaQ5qZ7lfE3LaEzztDoRjaKtFGZT3XzFNUW3xdk7mAh0IaYZJr94zMQH4rYpBu_IAIsfVyR5H_oUZ3xHgOz8FBcywxhwKUjCHAMEV6AduiXF7OJuT_Ky9nsCC9HkCvMEz6snA0wZX9zup9X3jx-uLj7Xl98-fbk4v6ydbNhSg5COmxZ6yXSDSlPeMYNoOqOlVKBd18pG4iAcBza4plMNSFViAntloBWn1fuj7m7tZuwdhiXBZHfJz5D2NoK3DyPBb-0Yf1ijNRW6KQJvbgVSvFkxL3b22eE0QcC4ZsulboVutVQFff0Xeh3XFEp5livOaGsEp_fUCBNaH4ZY7nUHUXuuTNtqyrQp1Nk_qDL7wx_FgIMv5w8S-DHBlZbnhMNdjYzag1Hs0Si2LPaXUezhxa_-7M5dym9nFEAcgVxCYcR0X9J_ZH8CHw_JiA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2621098320</pqid></control><display><type>article</type><title>Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla</title><source>SPORTDiscus</source><source>Springer Link</source><creator>Godlewska, Beata R. ; Williams, Stephen ; Emir, Uzay E. ; Chen, Chi ; Sharpley, Ann L. ; Goncalves, Ana Jorge ; Andersson, Monique I. ; Clarke, William ; Angus, Brian ; Cowen, Philip J.</creator><creatorcontrib>Godlewska, Beata R. ; Williams, Stephen ; Emir, Uzay E. ; Chen, Chi ; Sharpley, Ann L. ; Goncalves, Ana Jorge ; Andersson, Monique I. ; Clarke, William ; Angus, Brian ; Cowen, Philip J.</creatorcontrib><description>Rationale Chronic fatigue syndrome (CFS) is a common and burdensome illness with a poorly understood pathophysiology, though many of the characteristic symptoms are likely to be of brain origin. The use of high-field proton magnetic resonance spectroscopy (MRS) enables the detection of a range of brain neurochemicals relevant to aetiological processes that have been linked to CFS, for example, oxidative stress and mitochondrial dysfunction. Methods We studied 22 CFS patients and 13 healthy controls who underwent MRS scanning at 7 T with a voxel placed in the anterior cingulate cortex. Neurometabolite concentrations were calculated using the unsuppressed water signal as a reference. Results Compared to controls, CFS patients had lowered levels of glutathione, total creatine and myo -inositol in anterior cingulate cortex. However, when using N-acetylaspartate as a reference metabolite, only myo -inositol levels continued to be significantly lower in CFS participants. Conclusions The changes in glutathione and creatine are consistent with the presence of oxidative and energetic stress in CFS patients and are potentially remediable by nutritional intervention. A reduction in myo -inositol would be consistent with glial dysfunction. However, the relationship of the neurochemical abnormalities to the causation of CFS remains to be established, and the current findings require prospective replication in a larger sample.</description><identifier>ISSN: 0033-3158</identifier><identifier>EISSN: 1432-2072</identifier><identifier>DOI: 10.1007/s00213-021-05986-6</identifier><identifier>PMID: 34609538</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Aspartic Acid ; Biomedical and Life Sciences ; Biomedicine ; Brain research ; Chronic fatigue syndrome ; Cortex (cingulate) ; Creatine ; Development and progression ; Fatigue ; Fatigue Syndrome, Chronic - diagnostic imaging ; Glutathione ; Health aspects ; Humans ; Inositol ; Magnetic Resonance Imaging ; Magnetic Resonance Spectroscopy ; Metabolites ; Mitochondria ; N-Acetylaspartate ; Neurochemistry ; Neuronal-glial interactions ; Neurosciences ; Nuclear magnetic resonance spectroscopy ; Original Investigation ; Oxidative stress ; Pharmacology/Toxicology ; Physiological aspects ; Prospective Studies ; Psychiatry ; Spectrum analysis</subject><ispartof>Psychopharmacology, 2022-01, Vol.239 (1), p.163-171</ispartof><rights>The Author(s) 2021</rights><rights>2021. The Author(s).</rights><rights>COPYRIGHT 2022 Springer</rights><rights>The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c541t-a35c289ad5174e6702b18ee8b87556a7cb9545ef3c2a1fc4b64a567553ed68a93</citedby><cites>FETCH-LOGICAL-c541t-a35c289ad5174e6702b18ee8b87556a7cb9545ef3c2a1fc4b64a567553ed68a93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34609538$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Godlewska, Beata R.</creatorcontrib><creatorcontrib>Williams, Stephen</creatorcontrib><creatorcontrib>Emir, Uzay E.</creatorcontrib><creatorcontrib>Chen, Chi</creatorcontrib><creatorcontrib>Sharpley, Ann L.</creatorcontrib><creatorcontrib>Goncalves, Ana Jorge</creatorcontrib><creatorcontrib>Andersson, Monique I.</creatorcontrib><creatorcontrib>Clarke, William</creatorcontrib><creatorcontrib>Angus, Brian</creatorcontrib><creatorcontrib>Cowen, Philip J.</creatorcontrib><title>Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla</title><title>Psychopharmacology</title><addtitle>Psychopharmacology</addtitle><addtitle>Psychopharmacology (Berl)</addtitle><description>Rationale Chronic fatigue syndrome (CFS) is a common and burdensome illness with a poorly understood pathophysiology, though many of the characteristic symptoms are likely to be of brain origin. The use of high-field proton magnetic resonance spectroscopy (MRS) enables the detection of a range of brain neurochemicals relevant to aetiological processes that have been linked to CFS, for example, oxidative stress and mitochondrial dysfunction. Methods We studied 22 CFS patients and 13 healthy controls who underwent MRS scanning at 7 T with a voxel placed in the anterior cingulate cortex. Neurometabolite concentrations were calculated using the unsuppressed water signal as a reference. Results Compared to controls, CFS patients had lowered levels of glutathione, total creatine and myo -inositol in anterior cingulate cortex. However, when using N-acetylaspartate as a reference metabolite, only myo -inositol levels continued to be significantly lower in CFS participants. Conclusions The changes in glutathione and creatine are consistent with the presence of oxidative and energetic stress in CFS patients and are potentially remediable by nutritional intervention. A reduction in myo -inositol would be consistent with glial dysfunction. However, the relationship of the neurochemical abnormalities to the causation of CFS remains to be established, and the current findings require prospective replication in a larger sample.</description><subject>Aspartic Acid</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brain research</subject><subject>Chronic fatigue syndrome</subject><subject>Cortex (cingulate)</subject><subject>Creatine</subject><subject>Development and progression</subject><subject>Fatigue</subject><subject>Fatigue Syndrome, Chronic - diagnostic imaging</subject><subject>Glutathione</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Inositol</subject><subject>Magnetic Resonance Imaging</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Metabolites</subject><subject>Mitochondria</subject><subject>N-Acetylaspartate</subject><subject>Neurochemistry</subject><subject>Neuronal-glial interactions</subject><subject>Neurosciences</subject><subject>Nuclear magnetic resonance spectroscopy</subject><subject>Original Investigation</subject><subject>Oxidative stress</subject><subject>Pharmacology/Toxicology</subject><subject>Physiological aspects</subject><subject>Prospective Studies</subject><subject>Psychiatry</subject><subject>Spectrum analysis</subject><issn>0033-3158</issn><issn>1432-2072</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kk1v1DAQhiMEokvhD3BAlrhwSfFH_BEOSFXFl1TBpZytiTPJukrsrZ0g7b_Hy5aWIoQt2ZLnmdee8VtVLxk9Y5Tqt5lSzkRdlprK1qhaPao2rBG85lTzx9WGUiFqwaQ5qZ7lfE3LaEzztDoRjaKtFGZT3XzFNUW3xdk7mAh0IaYZJr94zMQH4rYpBu_IAIsfVyR5H_oUZ3xHgOz8FBcywxhwKUjCHAMEV6AduiXF7OJuT_Ky9nsCC9HkCvMEz6snA0wZX9zup9X3jx-uLj7Xl98-fbk4v6ydbNhSg5COmxZ6yXSDSlPeMYNoOqOlVKBd18pG4iAcBza4plMNSFViAntloBWn1fuj7m7tZuwdhiXBZHfJz5D2NoK3DyPBb-0Yf1ijNRW6KQJvbgVSvFkxL3b22eE0QcC4ZsulboVutVQFff0Xeh3XFEp5livOaGsEp_fUCBNaH4ZY7nUHUXuuTNtqyrQp1Nk_qDL7wx_FgIMv5w8S-DHBlZbnhMNdjYzag1Hs0Si2LPaXUezhxa_-7M5dym9nFEAcgVxCYcR0X9J_ZH8CHw_JiA</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Godlewska, Beata R.</creator><creator>Williams, Stephen</creator><creator>Emir, Uzay E.</creator><creator>Chen, Chi</creator><creator>Sharpley, Ann L.</creator><creator>Goncalves, Ana Jorge</creator><creator>Andersson, Monique I.</creator><creator>Clarke, William</creator><creator>Angus, Brian</creator><creator>Cowen, Philip J.</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QR</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220101</creationdate><title>Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla</title><author>Godlewska, Beata R. ; Williams, Stephen ; Emir, Uzay E. ; Chen, Chi ; Sharpley, Ann L. ; Goncalves, Ana Jorge ; Andersson, Monique I. ; Clarke, William ; Angus, Brian ; Cowen, Philip J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c541t-a35c289ad5174e6702b18ee8b87556a7cb9545ef3c2a1fc4b64a567553ed68a93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Aspartic Acid</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brain research</topic><topic>Chronic fatigue syndrome</topic><topic>Cortex (cingulate)</topic><topic>Creatine</topic><topic>Development and progression</topic><topic>Fatigue</topic><topic>Fatigue Syndrome, Chronic - diagnostic imaging</topic><topic>Glutathione</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Inositol</topic><topic>Magnetic Resonance Imaging</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Metabolites</topic><topic>Mitochondria</topic><topic>N-Acetylaspartate</topic><topic>Neurochemistry</topic><topic>Neuronal-glial interactions</topic><topic>Neurosciences</topic><topic>Nuclear magnetic resonance spectroscopy</topic><topic>Original Investigation</topic><topic>Oxidative stress</topic><topic>Pharmacology/Toxicology</topic><topic>Physiological aspects</topic><topic>Prospective Studies</topic><topic>Psychiatry</topic><topic>Spectrum analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Godlewska, Beata R.</creatorcontrib><creatorcontrib>Williams, Stephen</creatorcontrib><creatorcontrib>Emir, Uzay E.</creatorcontrib><creatorcontrib>Chen, Chi</creatorcontrib><creatorcontrib>Sharpley, Ann L.</creatorcontrib><creatorcontrib>Goncalves, Ana Jorge</creatorcontrib><creatorcontrib>Andersson, Monique I.</creatorcontrib><creatorcontrib>Clarke, William</creatorcontrib><creatorcontrib>Angus, Brian</creatorcontrib><creatorcontrib>Cowen, Philip J.</creatorcontrib><collection>SpringerOpen(OpenAccess)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Psychology Journals</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Psychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Godlewska, Beata R.</au><au>Williams, Stephen</au><au>Emir, Uzay E.</au><au>Chen, Chi</au><au>Sharpley, Ann L.</au><au>Goncalves, Ana Jorge</au><au>Andersson, Monique I.</au><au>Clarke, William</au><au>Angus, Brian</au><au>Cowen, Philip J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla</atitle><jtitle>Psychopharmacology</jtitle><stitle>Psychopharmacology</stitle><addtitle>Psychopharmacology (Berl)</addtitle><date>2022-01-01</date><risdate>2022</risdate><volume>239</volume><issue>1</issue><spage>163</spage><epage>171</epage><pages>163-171</pages><issn>0033-3158</issn><eissn>1432-2072</eissn><abstract>Rationale Chronic fatigue syndrome (CFS) is a common and burdensome illness with a poorly understood pathophysiology, though many of the characteristic symptoms are likely to be of brain origin. The use of high-field proton magnetic resonance spectroscopy (MRS) enables the detection of a range of brain neurochemicals relevant to aetiological processes that have been linked to CFS, for example, oxidative stress and mitochondrial dysfunction. Methods We studied 22 CFS patients and 13 healthy controls who underwent MRS scanning at 7 T with a voxel placed in the anterior cingulate cortex. Neurometabolite concentrations were calculated using the unsuppressed water signal as a reference. Results Compared to controls, CFS patients had lowered levels of glutathione, total creatine and myo -inositol in anterior cingulate cortex. However, when using N-acetylaspartate as a reference metabolite, only myo -inositol levels continued to be significantly lower in CFS participants. Conclusions The changes in glutathione and creatine are consistent with the presence of oxidative and energetic stress in CFS patients and are potentially remediable by nutritional intervention. A reduction in myo -inositol would be consistent with glial dysfunction. However, the relationship of the neurochemical abnormalities to the causation of CFS remains to be established, and the current findings require prospective replication in a larger sample.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>34609538</pmid><doi>10.1007/s00213-021-05986-6</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0033-3158
ispartof Psychopharmacology, 2022-01, Vol.239 (1), p.163-171
issn 0033-3158
1432-2072
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8770374
source SPORTDiscus; Springer Link
subjects Aspartic Acid
Biomedical and Life Sciences
Biomedicine
Brain research
Chronic fatigue syndrome
Cortex (cingulate)
Creatine
Development and progression
Fatigue
Fatigue Syndrome, Chronic - diagnostic imaging
Glutathione
Health aspects
Humans
Inositol
Magnetic Resonance Imaging
Magnetic Resonance Spectroscopy
Metabolites
Mitochondria
N-Acetylaspartate
Neurochemistry
Neuronal-glial interactions
Neurosciences
Nuclear magnetic resonance spectroscopy
Original Investigation
Oxidative stress
Pharmacology/Toxicology
Physiological aspects
Prospective Studies
Psychiatry
Spectrum analysis
title Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T20%3A59%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neurochemical%20abnormalities%20in%20chronic%20fatigue%20syndrome:%20a%20pilot%20magnetic%20resonance%20spectroscopy%20study%20at%207%20Tesla&rft.jtitle=Psychopharmacology&rft.au=Godlewska,%20Beata%20R.&rft.date=2022-01-01&rft.volume=239&rft.issue=1&rft.spage=163&rft.epage=171&rft.pages=163-171&rft.issn=0033-3158&rft.eissn=1432-2072&rft_id=info:doi/10.1007/s00213-021-05986-6&rft_dat=%3Cgale_pubme%3EA689970178%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c541t-a35c289ad5174e6702b18ee8b87556a7cb9545ef3c2a1fc4b64a567553ed68a93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2621098320&rft_id=info:pmid/34609538&rft_galeid=A689970178&rfr_iscdi=true